REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 171 filers reported holding REVOLUTION MEDICINES INC in Q3 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,038,475 | +3.2% | 218,153 | -0.2% | 0.08% | +5.4% |
Q2 2023 | $5,848,700 | +28.1% | 218,643 | +3.7% | 0.07% | +15.6% |
Q1 2023 | $4,565,235 | -11.4% | 210,768 | -2.6% | 0.06% | -16.9% |
Q4 2022 | $5,152,433 | +19.2% | 216,307 | -1.3% | 0.08% | +18.5% |
Q3 2022 | $4,323,000 | -54.2% | 219,197 | +6.5% | 0.06% | -53.2% |
Q1 2021 | $9,442,000 | – | 205,788 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |